Live·Open questions in longevity research
← Questions

Can aging human skin be shifted into a stable, youthful functional state, and what minimal set of changes in cells, the extracellular matrix, stem cell niches, the vasculature, and the nervous system is necessary and jointly sufficient to achieve and maintain this transition?

Does repeated repair-only growth stimulation restrain abnormal cell families in sun-aged human skin, or favor those with other mutations?

The proposed benefit depends on stimulation helping repair while any advantage in cell renewal ends when each repair finishes. If abnormal cell families retain a relative advantage, repeated repairs could change the skin's cellular composition even when every wound closes normally.

The whole reason

Wound closure would then fail to capture the persistent change that the question seeks to detect. Conversely, continued restraint would support the proposed protective effect, although restraint alone would not establish that cancer risk remains unchanged.

The question in full

The question concerns whether repeated, temporary stimulation of skin repair changes which abnormal cell families persist afterward. It asks whether activating the epidermal growth factor receptor (EGFR), a protein that receives growth signals, only during repair restrains abnormal clones in naturally sun-aged human skin containing cells with different genetic changes. The alternative is that repeated treatments favor clones with changes outside the RAS group of genes, leaving those clones enriched even after wounds close normally and stimulation stops completely. The comparison is whether these abnormal cell families remain restrained or become persistently more common across repeated repairs. The question assumes that protective competition from normal cells has already been demonstrated in engineered mouse wounds containing RAS-altered cells, but the supplied sources do not establish that premise.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

  1. 01Repeated skin repair lets surviving cells inherit DNA from dying neighboursIn naturally photoaged human epidermis, repeated repair supported by epidermal growth factor receptor (EGFR) stimulation may give surviving cells a lasting advantage through inherited donor DNA. Heritable integration and loss of that advantage when transfer is prevented would distinguish this mechanism.
  2. 02Repeated growth signals favor abnormal skin cell clones by crowding dividing neighborsIn donor-derived organotypic epidermis, repeated epidermal growth factor receptor (EGFR) pulses would favor compression-resistant clones through synchronized division. Eliminating crowding by staggering pulses or increasing available area would prevent enrichment; continued enrichment would reject the mechanism.
  3. 03Renewal signals turn lingering ultraviolet damage into lasting mutations in aged skinIn photoaged skin with low stromal insulin-like growth factor 1, epidermal growth factor receptor stimulation may fix ultraviolet damage as inherited mutations. Removing lesions before repeated stimulation would prevent new variants and lasting competitive gains; unchanged baseline genotypes would reject the mechanism.
Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe
In donor-matched endogenous mosaics, expanding recipient lineages acquire donor-private linked nuclear variants with integration junctions absent from their baseline genomes. Recipient identity remains independently traceable, and acquisition persists through daughter-cell divisions after withdrawal. Degrading DNA within experimentally isolated apoptotic material before reconstitution prevents these acquisitions and subsequent competitive gains, whereas equivalent intact material restores them. Equal corpse mass, inflammatory exposure, closure, and cumulative divisions are required controls. Absence of verified heritable transfer at a sensitivity sufficient to explain observed enrichment rejects this mechanism. Hypothetical result
Would support the hypothesis
Repeated skin repair lets surviving cells inherit DNA from dying neighbours — In naturally photoaged human epidermis, repeated repair supported by epidermal growth factor receptor (EGFR) stimulation may give surviving cells a lasting advantage through inherited donor DNA. Heritable integration and loss of that advantage when transfer is prevented would distinguish this mechanism.
Other hypotheses predict
  • Repeated growth signals favor abnormal skin cell clones by crowding dividing neighbors — Compare globally simultaneous with spatially staggered pulses while matching local ligand exposure, integrated receptor activation, cumulative divisions, injury, and closure. Simultaneous pulses produce greater peak local compression, preferential normal-cell basal exit, and larger non-RAS clone increments. Staggering abolishes enrichment when neighboring mitotic occupancy ceases to overlap; mechanically increasing available area provides an independent rescue. Genotypes and transferred-DNA junctions remain unchanged. Continued enrichment after eliminating crowding peaks rejects this mechanism.
  • Renewal signals turn lingering ultraviolet damage into lasting mutations in aged skin — In a factorial experiment varying UV-to-pulse delay and stromal IGF-1 status, short-delay repeated pulses preferentially generate newly branched mutant descendants when IGF-1 support is low. Validated lesion-specific photorepair before stimulation prevents the excess new variants and subsequent competitive advantage despite matched receptor activation and cumulative divisions. Staggering neighboring mitoses without removing photolesions does not provide equivalent protection. Expansion consisting entirely of unchanged baseline genotypes rejects this mechanism as the principal explanation.
What to check next
Does repeated EGFR stimulation limited to repair restrain or persistently enrich non-RAS abnormal cell families in naturally sun-aged human skin after wounds close and stimulation stops?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

01

Repeated skin repair lets surviving cells inherit DNA from dying neighbours

Horizontal somatic genome acquisition
Proposed mechanism

In naturally photoaged human epidermis, repeated repair supported by epidermal growth factor receptor (EGFR) stimulation may give surviving cells a lasting advantage through inherited donor DNA.

Full text

Repeated EGFR-supported repair promotes horizontal acquisition of nuclear DNA from dying keratinocytes by surviving, checkpoint-defective non-RAS keratinocytes. Rare acquired fragments become heritable and confer additional competitive advantage. Thus, eliminating one damaged lineage can genetically potentiate another even when stimulation stops completely. The persistent substrate is newly integrated donor DNA, rather than continued EGFR activity or simple expansion of the original donor clone. Preventing heritable acquisition would stabilize SPV_10 while preserving repair.

What distinguishes its prediction

In donor-matched endogenous mosaics, expanding recipient lineages acquire donor-private linked nuclear variants with integration junctions absent from their baseline genomes.

Full text

Recipient identity remains independently traceable, and acquisition persists through daughter-cell divisions after withdrawal. Degrading DNA within experimentally isolated apoptotic material before reconstitution prevents these acquisitions and subsequent competitive gains, whereas equivalent intact material restores them. Equal corpse mass, inflammatory exposure, closure, and cumulative divisions are required controls. Absence of verified heritable transfer at a sensitivity sufficient to explain observed enrichment rejects this mechanism.

What would weaken the hypothesis

Repeated growth signals favor abnormal skin cell clones by crowding dividing neighbors predicts instead: Compare globally simultaneous with spatially staggered pulses while matching local ligand exposure, integrated receptor activation, cumulative divisions, injury, and closure.

Full text

Simultaneous pulses produce greater peak local compression, preferential normal-cell basal exit, and larger non-RAS clone increments. Staggering abolishes enrichment when neighboring mitotic occupancy ceases to overlap; mechanically increasing available area provides an independent rescue. Genotypes and transferred-DNA junctions remain unchanged. Continued enrichment after eliminating crowding peaks rejects this mechanism.

Renewal signals turn lingering ultraviolet damage into lasting mutations in aged skin predicts instead: In a factorial experiment varying UV-to-pulse delay and stromal IGF-1 status, short-delay repeated pulses preferentially generate newly branched mutant descendants when IGF-1 support is low. Validated lesion-specific photorepair before stimulation prevents the excess new variants and subsequent competitive advantage despite matched receptor activation and cumulative divisions. Staggering neighboring mitoses without removing photolesions does not provide equivalent protection. Expansion consisting entirely of unchanged baseline genotypes rejects this mechanism as the principal explanation.

02

Repeated growth signals favor abnormal skin cell clones by crowding dividing neighbors

Structure and topology
Proposed mechanism

In donor-derived organotypic epidermis, repeated epidermal growth factor receptor (EGFR) pulses would favor compression-resistant clones through synchronized division.

Full text

Repeated EGFR pulses synchronize neighboring mitoses sufficiently to create brief mechanical crowding peaks. Non-RAS clones resistant to compression-associated basal exit survive these peaks better than normal neighbors, even if their EGFR response and total division count are no greater. Each pulse therefore leaves a real territorial increment after complete withdrawal. The causal defect is simultaneous physical occupancy during division; disrupting that simultaneity would stabilize SPV_10 without reducing cumulative renewal.

What distinguishes its prediction

Compare globally simultaneous with spatially staggered pulses while matching local ligand exposure, integrated receptor activation, cumulative divisions, injury, and closure.

Full text

Simultaneous pulses produce greater peak local compression, preferential normal-cell basal exit, and larger non-RAS clone increments. Staggering abolishes enrichment when neighboring mitotic occupancy ceases to overlap; mechanically increasing available area provides an independent rescue. Genotypes and transferred-DNA junctions remain unchanged. Continued enrichment after eliminating crowding peaks rejects this mechanism.

What would weaken the hypothesis

Repeated skin repair lets surviving cells inherit DNA from dying neighbours predicts instead: In donor-matched endogenous mosaics, expanding recipient lineages acquire donor-private linked nuclear variants with integration junctions absent from their baseline genomes.

Full text

Recipient identity remains independently traceable, and acquisition persists through daughter-cell divisions after withdrawal. Degrading DNA within experimentally isolated apoptotic material before reconstitution prevents these acquisitions and subsequent competitive gains, whereas equivalent intact material restores them. Equal corpse mass, inflammatory exposure, closure, and cumulative divisions are required controls. Absence of verified heritable transfer at a sensitivity sufficient to explain observed enrichment rejects this mechanism.

Renewal signals turn lingering ultraviolet damage into lasting mutations in aged skin predicts instead: In a factorial experiment varying UV-to-pulse delay and stromal IGF-1 status, short-delay repeated pulses preferentially generate newly branched mutant descendants when IGF-1 support is low. Validated lesion-specific photorepair before stimulation prevents the excess new variants and subsequent competitive advantage despite matched receptor activation and cumulative divisions. Staggering neighboring mitoses without removing photolesions does not provide equivalent protection. Expansion consisting entirely of unchanged baseline genotypes rejects this mechanism as the principal explanation.

03

Renewal signals turn lingering ultraviolet damage into lasting mutations in aged skin

Covalent genome damage fixation
Proposed mechanism

In photoaged skin with low stromal insulin-like growth factor 1, epidermal growth factor receptor stimulation may fix ultraviolet damage as inherited mutations.

Full text

In photoaged skin with inadequate stromal IGF-1 support, EGFR-driven renewal increases replication through residual UV photolesions. Repeated pulses generate additional heritable mutations within existing non-RAS lineages; occasional secondary alterations then sustain competitive advantage after withdrawal. The substrate is newly fixed genomic damage, rather than preferential stimulation of an unchanged baseline genotype. Removing photolesions before renewal would stabilize SPV_10 while retaining EGFR-assisted closure.

What distinguishes its prediction

In a factorial experiment varying UV-to-pulse delay and stromal IGF-1 status, short-delay repeated pulses preferentially generate newly branched mutant descendants when IGF-1 support is low.

Full text

Validated lesion-specific photorepair before stimulation prevents the excess new variants and subsequent competitive advantage despite matched receptor activation and cumulative divisions. Staggering neighboring mitoses without removing photolesions does not provide equivalent protection. Expansion consisting entirely of unchanged baseline genotypes rejects this mechanism as the principal explanation.

What would weaken the hypothesis

Repeated skin repair lets surviving cells inherit DNA from dying neighbours predicts instead: In donor-matched endogenous mosaics, expanding recipient lineages acquire donor-private linked nuclear variants with integration junctions absent from their baseline genomes.

Full text

Recipient identity remains independently traceable, and acquisition persists through daughter-cell divisions after withdrawal. Degrading DNA within experimentally isolated apoptotic material before reconstitution prevents these acquisitions and subsequent competitive gains, whereas equivalent intact material restores them. Equal corpse mass, inflammatory exposure, closure, and cumulative divisions are required controls. Absence of verified heritable transfer at a sensitivity sufficient to explain observed enrichment rejects this mechanism.

Repeated growth signals favor abnormal skin cell clones by crowding dividing neighbors predicts instead: Compare globally simultaneous with spatially staggered pulses while matching local ligand exposure, integrated receptor activation, cumulative divisions, injury, and closure. Simultaneous pulses produce greater peak local compression, preferential normal-cell basal exit, and larger non-RAS clone increments. Staggering abolishes enrichment when neighboring mitotic occupancy ceases to overlap; mechanically increasing available area provides an independent rescue. Genotypes and transferred-DNA junctions remain unchanged. Continued enrichment after eliminating crowding peaks rejects this mechanism.

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: Does repeated EGFR stimulation limited to repair restrain or persistently enrich non-RAS abnormal cell families in naturally sun-aged human skin after wounds close and stimulation stops?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Does repeated repair-only growth stimulation restrain abnormal cell families in sun-aged human skin, or favor those with other mutations?

What this question is asking

The question concerns whether repeated, temporary stimulation of skin repair changes which abnormal cell families persist afterward. It asks whether activating the epidermal growth factor receptor (EGFR), a protein that receives growth signals, only during repair restrains abnormal clones in naturally sun-aged human skin containing cells with different genetic changes. The alternative is that repeated treatments favor clones with changes outside the RAS group of genes, leaving those clones enriched even after wounds close normally and stimulation stops completely. The comparison is whether these abnormal cell families remain restrained or become persistently more common across repeated repairs. The question assumes that protective competition from normal cells has already been demonstrated in engineered mouse wounds containing RAS-altered cells, but the supplied sources do not establish that premise.

What the terms mean
Epidermal growth factor receptor (EGFR)
A protein that receives growth signals. Activating it during repair is the intervention being questioned; receptor expression in a cancer is a different observation from the effects of temporarily stimulating it during wound repair.
Repair-limited stimulation and repeated pulses
Stimulation restricted to periods of repair, delivered on multiple occasions. These phrases do not specify a dose, treatment duration, or stopping rule in the supplied input.
Naturally photoaged skin
Human skin changed by accumulated sunlight exposure. It is the setting named by the question, rather than an experimentally engineered mouse wound.
Clone or cell family
Cells descended from a common starting cell. An abnormal clone carries changes of concern in this question, but the label alone does not establish that the cells are cancerous.
Mosaic
Tissue containing cell groups with different genetic makeups. Here, the distinction is between naturally occurring human variation and an experimentally engineered mixture in mice.
RAS and non-RAS
RAS names a group of genes used to distinguish the engineered mouse clones from other genetically altered clones. Non-RAS is a broad grouping of other changes, not one defined cell type; the supplied material does not identify the individual changes at issue.
Normal-cell competition
The proposed process in which normal cells limit the persistence or expansion of abnormal cell families. Its protective role in the stated mouse setting is a premise of the question, not a finding established by the supplied sources.
Selection, enrichment, and renewal advantage
Selection means that some cell families are favored over others; enrichment means that their relative representation increases. A renewal advantage is an advantage in replenishing cells, and the question asks whether such an advantage ends with repair or leaves cumulative changes.
RL-1
A label attached to the engineered mouse work in the gap description. The supplied material does not explain what the label denotes.
Cutaneous squamous-cell carcinoma
A type of skin cancer examined in both supplied sources. Findings in an existing cancer do not directly establish what happens during repair of naturally sun-aged skin.
Metastasis
The spread of cancer to other sites. S2's quoted suggestion concerns this outcome, rather than abnormal cell enrichment following repeated wound repair.
p63 and p73
Named regulators of gene activity studied in S5. The supplied quote identifies their joint regulation of several molecules that activate EGFR.
EGFR ligands
Molecules that bind to EGFR and provide signals through it. S5 discusses multiple such molecules, so the term names a class rather than a single substance.
Feed-forward signaling module
A connected set of regulatory steps that reinforces a downstream signal. S5 reports that the module involving p63, p73, and EGFR ligands amplifies signals promoting cell multiplication.
Preprint
A research manuscript shared before formal journal publication. S5 is identified as a preprint; the supplied input does not establish its peer-review status.
What the question takes for granted
Premise not found in what was read
RL-1 engineered RAS-mosaic mouse wounds show protective normal-cell competition under repair-limited EGFR stimulation.

The assumption concerns experimentally altered mouse wounds containing a mixture of cells, including cells with changes in RAS genes, and a treatment that activates a growth-signal receptor only during repair. It claims that normal cells compete in a way that restrains abnormal cell families in this setting. If established, this would provide the mouse finding whose persistence in genetically varied, sun-aged human skin is being questioned.

Neither supplied source establishes the claimed RL-1 mouse result or protective normal-cell competition. S2 concerns receptor expression in an existing skin cancer, and S5 concerns a growth-signaling mechanism in skin cancer. The supplied search results therefore do not establish this premise; that does not show that the premise is false.S2S5

The same question asked without the part nothing read establishes:

  • Does repeated EGFR stimulation limited to repair restrain or persistently enrich non-RAS abnormal cell families in naturally sun-aged human skin after wounds close and stimulation stops?
  • Does normal wound closure after repeated repair-limited EGFR stimulation coincide with lasting changes in the relative abundance of abnormal cell families in naturally sun-aged human skin?
What turns on the answer
  • Abnormal cell families remain restrained Under the proposed competition mechanism, repair stimulation would help normal cells limit abnormal cell families without giving those abnormal families a lasting advantage. Repeated closure would then be compatible with continued restraint after stimulation stops, although unchanged cancer risk would remain a separate requirement.
  • Non-RAS abnormal cell families become persistently enriched Repeated repair stimulation would favor some cell families carrying changes outside the RAS group, and their increased representation would remain after the treatment ends. Normal wound closure and complete treatment cessation would therefore be insufficient evidence that the treatment's effects on cellular composition had ended.
Why it matters

The proposed benefit depends on stimulation helping repair while any advantage in cell renewal ends when each repair finishes. If abnormal cell families retain a relative advantage, repeated repairs could change the skin's cellular composition even when every wound closes normally. Wound closure would then fail to capture the persistent change that the question seeks to detect. Conversely, continued restraint would support the proposed protective effect, although restraint alone would not establish that cancer risk remains unchanged.

Could not be determined

Only two background sources were supplied. S2 suggests preferential spread of an EGFR-expressing clone in some existing skin cancers; S5 reports amplification of growth signaling in skin cancer. Neither examines the repair treatment, human skin setting, repeated exposures, or persistence after cessation that would settle the question. The inference from their scope is that the read evidence is too thin to determine whether this gap is already answered elsewhere in the literature.S2S5

What the literature establishes
  • S2 reports findings suggesting that, in some cutaneous squamous-cell carcinomas, a clone expressing EGFR might preferentially spread to other sites. The quoted conclusion is tentative and concerns existing cancer.S2
  • S5 reports that p63 and p73 jointly regulate multiple EGFR ligands, forming a feed-forward signaling module that amplifies signals promoting cell multiplication in cutaneous squamous-cell carcinoma. The source is a preprint.S5
What it does not settle
  • The supplied sources do not establish whether repair-limited EGFR stimulation restrains abnormal clones in naturally photoaged human skin containing genetically different cell families.S2S5
  • They do not establish whether repeated stimulation enriches particular non-RAS clones, whether any enrichment persists after stimulation stops, or whether it occurs despite normal wound closure.S2S5
  • The input supplies no treatment schedule, duration of follow-up, magnitude of persistent enrichment, or criterion for deciding that a renewal advantage has ended.
  • Neither source establishes whether the proposed repair treatment increases malignancy, meaning cancer development or progression, over the follow-up required by the question.S2S5
Sources read · 2

4 literature searches, 8 full texts; 8 source(s) read in full against this question. A bounded search is not evidence of absence.

S2Background

Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. · Dermatology (Basel, Switzerland) · 2001

“Our findings suggest that the clone with EGFR expression might selectively metastasize in some cutaneous SCCs.”

Does not settle: This source does not examine naturally photoaged human mosaics, repair-limited or repeated EGFR stimulation, wound closure, cessation of stimulation, or selection of non-RAS clones.

S5Background

p63 and p73 regulate convergent and factor-specific transcriptional programs in cutaneous squamous cell carcinoma. · bioRxiv : the preprint server for biology · 2026

“Among shared downstream targets, p63/p73 co-regulation of multiple epidermal growth factor receptor (EGFR) ligands establishes a feed-forward signaling module that amplifies mitogenic signaling.”

Does not settle: This source text does not address repair-limited EGFR stimulation, naturally photoaged human epidermal mosaics, abnormal-clone restraint or selection, repeated stimulation pulses, RAS versus non-RAS clones, wound closure, or effects after stimulation stops.

← Every open question